Journal article
Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines
Abstract
IMPORTANCE: Vaccination against SARS-CoV-2 is a highly effective strategy to prevent infection and severe COVID-19 outcomes. The best strategy for a second dose of vaccine among persons who had an immediate allergic reaction to their first SARS CoV-2 vaccination is unclear.
OBJECTIVE: To assess the risk of severe immediate allergic reactions (eg, anaphylaxis) to a second dose of SARS-CoV-2 mRNA vaccine among persons with immediate allergic …
Authors
Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M
Journal
JAMA Internal Medicine, Vol. 182, No. 4, pp. 376–385
Publisher
American Medical Association (AMA)
Publication Date
April 1, 2022
DOI
10.1001/jamainternmed.2021.8515
ISSN
2168-6106